Amlodipine or lisinopril was not better than chlorthalidone in lowering CHD risk in hypertension

Psaty, Bruce M.
July 2003
ACP Journal Club;Jul/Aug2003, Vol. 139 Issue 1, p7
Academic Journal
Deals with the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Risk factors for coronary heart disease; Main outcome measures; Overview of the ALLHAT trial.


Related Articles

  • No relation between coronary artery disease or electrocardiographic markers of disease in middle age and prenatal exposure to the Dutch famine of 1944e5. Lumey, L. H.; Martini, Lauren H.; Myerson, Merle.; Stein, Aryeh D.; Prineas, Ronald J. // Heart;Nov2012, Vol. 98 Issue 22, p1653 

    Objective and Setting Associations between prenatal famine and coronary artery disease (CAD) have been examined before with inconsistent results. For further evaluation, we examined multiple cardiac risk markers in adult men and women with prenatal exposure to the Dutch famine of 1944e5. Design...

  • Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women. Nordestgaard, Borge G.; Benn, Marianne; Schnohr, Peter; Tybjaerg-Hansen, Anne // JAMA: Journal of the American Medical Association;7/18/2007, Vol. 298 Issue 3, p299 

    This article reports on a clinical trial on nonfasting triglycerides and the risk of myocardial infarction, ischemic heart disease, and death in men and women. The objective of the trial was to test the hypothesis that very high levels of nonfasting triglycerides predict myocardial infarction...

  • Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative. Bhatt, Deepak L.; Roe, Matthew T.; Peterson, Eric D.; Li, Yun; Chen, Anita Y.; Harrington, Robert A.; Greenbaum, Adam B.; Berger, Peter B.; Cannon, Christopher P.; Cohen, David J.; Gibson, C. Michael; Saucedo, Jorge F.; Kleiman, Neal S.; Hochman, Judith S.; Boden, William E.; Brindis, Ralph G.; Peacock, W. Frank; Smith,, Sidney C.; Pollack,, Charles V.; Gibler, W. Brian // JAMA: Journal of the American Medical Association;11/3/2004, Vol. 292 Issue 17, p2096 

    Context The American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the management of non–ST-segment elevation acute coronary syndromes (NSTE ACS) recommend early invasive management for high-risk patients, given the benefits with this approach demonstrated in...

  • Is Metabolic Syndrome Predictive of Prevalence, Extent, and Risk of Coronary Artery Disease beyond Its Components? Results from the Multinational Coronary CT Angiography Evaluation for Clinical Outcome: An International Multicenter Registry (CONFIRM). Ahmadi, Amir; Leipsic, Jonathon; Feuchtner, Gudrun; Gransar, Heidi; Kalra, Dan; Heo, Ran; Achenbach, Stephan; Andreini, Daniele; Al-Mallah, Mouaz; Berman, Daniel S.; Budoff, Matthew; Cademartiri, Filippo; Callister, Tracy Q.; Chang, Hyuk-Jae; Chinnaiyan, Kavitha; Chow, Benjamin; Cury, Ricardo C.; Delago, Augustin; Gomez, Millie J.; Hadamitzky, Martin // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Although metabolic syndrome is associated with increased risk of cardiovascular disease and events, its added prognostic value beyond its components remains unknown. This study compared the prevalence, severity of coronary artery disease (CAD), and prognosis of patients with metabolic syndrome...

  • ST-segment changes in high-resolution body surface potential maps measured during exercise to assess myocardial ischemia: a pilot study. Kania, Michał; Zaczek, Rajmund; Zavala-Fernandez, Heriberto; Janusek, Dariusz; Kobylecka, Małgorzata; Królicki, Leszek; Opolski, Grzegorz; Maniewski, Roman // Archives of Medical Science;Dec2014, Vol. 10 Issue 6, p1086 

    Introduction: The aim of the study was to assess myocardial ischemia by analysis of ST-segment changes in high-resolution body surface potential maps (HR-BSPM) measured at rest and during an exercise stress test. Material and methods: The study was carried out on a group of 28 patients with...

  • Ezetimibe/Simvastatin: A Guide to its Clinical Use in Hypercholesterolemia. Lyseng-Williamson, Katherine A. // American Journal of Cardiovascular Drugs;2012, Vol. 12 Issue 1, p49 

    Ezetimibe/simvastatin therapy combines two lipid-lowering compounds with complementary mechanisms of action, thereby blocking the two sources of plasma cholesterol and improving lipid profiles. Ezetimibe/ simvastatin is an effective and generally well tolerated adjunct to dietary therapy for...

  • A Comparison of Risk Factors for Coronary Heart Disease and Ischaemic Stroke: The Dubbo Study of Australian Elderly. Simons, Leon A.; Simons, Judith; Friedlander, Yechiel; McCallum, John // Heart, Lung & Circulation;Oct2009, Vol. 18 Issue 5, p330 

    Background: Conventional risk factors for coronary heart disease (CHD) and ischaemic stroke (IS) have been well documented. This study examines whether there is a unique pattern of risk factors for each disease. Methods: This is a prospective cohort study in Dubbo NSW which has followed 2805 men...

  • Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification. Kavousi, Maryam; Elias-Smale, Suzette; Rutten, Joost H. W.; Leening, Maarten J. G.; Vliegenthart, Rozemarijn; Verwoert, Germaine C.; Krestin, Gabriel P.; Oudkerk, Matthijs; de Maat, Moniek P. M.; Leebeek, Frank W. G.; Mattace-Raso, Francesco U. S.; Lindemans, Jan; Hofman, Albert; Steyerberg, Ewout W.; der Lugt, Aad van; den Meiracker, Anton H. van; Witteman, Jacqueline C. M. // Annals of Internal Medicine;3/20/2012, Vol. 156 Issue 6, p438 

    Background: Whether newer risk markers for coronary heart disease (CHD) improve CHD risk prediction remains unclear. Objective: To assess whether newer risk markers for CHD risk prediction and stratification improve Framingham risk score (FRS) predictions. Design: Prospective population-based...

  • HIV Infection and Coronary Heart Disease: An Intersection of Epidemics. Triant, Virginia A. // Journal of Infectious Diseases;May2012 Supplement 3, Vol. 205 Issue suppl_3, pS355 

    Patients with human immunodeficiency virus (HIV) infection are at increased risk of developing coronary heart disease (CHD). Although factors potentially contributing to this elevated risk include traditional CHD risk factors and antiretroviral medications, more recent data support a role for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics